S
Sherif Mogawer
Researcher at Cairo University
Publications - 25
Citations - 1008
Sherif Mogawer is an academic researcher from Cairo University. The author has contributed to research in topics: Liver transplantation & Liver disease. The author has an hindex of 8, co-authored 24 publications receiving 874 citations.
Papers
More filters
Journal ArticleDOI
A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt
William Sievert,Ibrahim Altraif,Homie Razavi,Ayman A. Abdo,Ezzat Ali Ahmed,Ahmed Alomair,Deepak Amarapurkar,Chien-Hung Chen,Xiaoguang Dou,Hisham El Khayat,Mohamed elShazly,Gamal Esmat,Richard Guan,Kwang Hyub Han,Kazuhiko Koike,Angela Largen,Geoff McCaughan,Sherif Mogawer,Ali Monis,Arif Nawaz,Teerha Piratvisuth,Faisal M. Sanai,Ala I. Sharara,Scott Sibbel,Ajit Sood,Dong Jin Suh,Carolyn Wallace,Kendra A. Young,Francesco Negro +28 more
TL;DR: The hepatitis C pandemic has been systematically studied and characterized in North America and Europe, but this important public health problem has not received equivalent attention in other regions.
Journal ArticleDOI
Phase II Trial: Undifferentiated Versus Differentiated Autologous Mesenchymal Stem Cells Transplantation in Egyptian Patients with HCV Induced Liver Cirrhosis
Mervat El-Ansary,Iman Abdel-Aziz,Sherif Mogawer,Samah M. Abdel-Hamid,Olfat Hammam,Salwa Teaema,Marwa Wahdan +6 more
TL;DR: Bone marrow MSCs transplantation either undifferentiated or differentiated can be used as a potential treatment for liver cirrhosis, according to clinical and laboratory findings.
Journal ArticleDOI
Liver fibrosis: Consensus recommendations of the Asian Pacific association for the study of the liver (APASL)
Gamal Shiha,Shiv Kumar Sarin,Alaa Ibrahim,Masao Omata,Ashok Kumar,Laurentius A. Lesmana,Nancy Leung,Nurdan Tözün,Saeed Hamid,Wasim Jafri,Hitoshi Maruyama,Pierre Bedossa,Massimo Pinzani,Yogesh Chawla,Gamal Esmat,Wahed Doss,Taher Elzanaty,Puja Sakhuja,Ahmed Medhat Nasr,Ashraf Omar,Chun-Tao Wai,Ahmed Abdallah,Mohsen Salama,Abdelkhalek Hamed,Ayman Yousry,Imam Waked,Medhat Elsahar,Amr Fateen,Sherif Mogawer,Hassan Hamdy,Reda Elwakil +30 more
TL;DR: The Oxford System of evidence-based approach was adopted for developing the consensus statements using the level of evidence from 1 (highest) to 5 (lowest) and grade of recommendation from A (strongest) to D (weakest).
Journal ArticleDOI
Immunotherapy by autologous dendritic cell vaccine in patients with advanced HCC
Mervat El Ansary,Sherif Mogawer,Samah Abd El-Hamid,Sahr Alwakil,Fatma Aboelkasem,Hatem E. Sabaawy,Olfat Abdelhalim +6 more
TL;DR: Autologous DC vaccination in advanced HCC patients is safe and well tolerate, and improvement in overall survival was observed.
Journal ArticleDOI
The case for simplifying and using absolute targets for viral hepatitis elimination goals.
Homie Razavi,Sarah Blach,Devin Razavi-Shearer,Faisal Abaalkhail,Zaigham Abbas,Ayat R. Abdallah,Paulo Roberto Abrão Ferreira,Laith Jamal Abu Raddad,Danjuma Adda,Kosh Agarwal,Alessio Aghemo,Aijaz Ahmed,Said A. Al-Busafi,Waleed Al-Hamoudi,Saad Al-Kaabi,Hamad Al-Romaihi,Badr Aljarallah,Khalid Al-Naamani,Saleh A. Alqahtani,Khalid Alswat,Ibrahim Altraif,Tarik Asselah,Bruce R. Bacon,Fernando Bessone,Abdul Rahman Bizri,Tim Block,Ferruccio Bonino,Carlos Eduardo Brandão-Mello,Kimberly A. Brown,Philip Bruggmann,Maurizia Rossana Brunetto,Maria Buti,Joaquín Cabezas,Jose Luis Calleja,Erika Castro Batänjer,Henry Lik-Yuen Chan,Henry Chang,Chien-Jen Chen,Peer Brehm Christensen,Wan-Long Chuang,Laura Cisneros,Chari Cohen,Massimo Colombo,Brian Conway,Curtis Cooper,Antonio Craxì,Javier Crespo,E. A. Croes,Donna Cryer,Fernando Passos Cupertino de Barros,Moutaz Derbala,John F. Dillon,Wahid Doss,Xiaoguang Dou,Joseph Doyle,Ann-Sofi Duberg,Ellen Dugan,Rick Dunn,Geoffrey Dusheiko,Hisham El Khayat,Manal H El-Sayed,Ahad Eshraghian,Gamal Esmat,Rafael Esteban Mur,Sameera Ezzat,Karolin Falconer,Eduardo Fassio,Paulo Ferrinho,Steven L. Flamm,Robert Flisiak,Graham R. Foster,James Fung,Javier García-Samaniego,Robert G. Gish,Fernando L. Gonçales,Waldemar Halota,Waseem Hamoudi,Mohamed Hassany,Angelos Hatzakis,Susan Hay,Sayed Himatt,I. M. Hoepelman,Yao‐Chun Hsu,Yee Tak Hui,Béla Hunyady,Ira M. Jacobson,Naveed Z. Janjua,Harry L.A. Janssen,Peter Jarcuska,Kenneth Kabagambe,Tatsuya Kanto,Jia-Horng Kao,Sabahattin Kaymakoglu,David Kershenobich,Faryal Khamis,Dong Joon Kim,Do Young Kim,Loreta A. Kondili,Shyamasundaran Kottilil,Anna Kramvis,Marcelo Kugelmas,Masayuki Kurosaki,Karine Lacombe,Martin Lagging,Wai-cheung C Lao,Daniel Lavanchy,Jeffrey V. Lazarus,Alice Lee,Samual S Lee,Miriam T. Levy,Valentina Liakina,Young-Suk Lim,Shuang Liu,Willis Maddrey,Reza Malekzadeh,Rui Tato Marinho,Poonam Mathur,Mojca Matičič,Maria C Mendes Correa,Jorge Mera,Shahin Merat,Sherif Mogawer,Rosmawati Mohamed,Beat Muellhaupt,David H. Muljono,Ibrahim Mostafa,Mendez Sanchez Nahum,Arif Nawaz,Francesco Negro,Michael Ninburg,Qing Ning,Boatemaa Ntiri‐ Reid,Pagbajabyn Nymadawa,Anne Oevrehus,Necati Örmeci,Mauricio Orrego,Alaa Osman,Tsendsuren S. Oyunsuren,Calvin Q. Pan,Vassiliki Papaevangelou,George V. Papatheodoridis,Stephanie Popping,Papu Prasad,Rittoo Prithiviputh,Huma Qureshi,Alnoor Ramji,Kathryn Razavi-Shearer,Rajender Reddy,William Remak,Clemens Richter,Ezequiel Ridruejo,Geert Robaeys,Stuart K. Roberts,Lewis R. Roberts,Françoise Roudot-Thoraval,Sammy Saab,Sanaa Said,Amjad Salamat,Faisal M. Sanai,Juan Francisco Sánchez-Ávila,Eugene R. Schiff,Raymond F. Schinazi,Giada Sebastiani,Carole Seguin-Devaux,R. P. Shanmugam,Ala I. Sharara,Sonjelle Shilton,Daniel Shouval,William Sievert,Marieta Simonova,Amir Ali Sohrabpour,Mark W. Sonderup,Alejandro Soza,C Wendy Spearman,Nancy Steinfurth,Mark S. Sulkowski,Soek-Siam Tan,Junko Tanaka,Dhondup Tashi,Hla-Hla Thein,Peyton Thompson,Ieva Tolmane,Mehlika Toy,Jonas Valantinas,David A. M. C. van de Vijver,Patricia Vélez‐Möller,Adriana Vince,Imam Waked,Su Wang,Heiner Wedemeyer,Vincent Wai-Sun Wong,Qing Xie,Seiji Yamada,Hwai I. Yang,Kakharman Yesmembetov,Yusuf Yilmaz,Zobair M. Younossi,Ming-Lung Yu,Man-Fung Yuen,Cihan Yurdaydin,Aasim Yusuf,Amany Zekry,Stefan Zeuzem +202 more
TL;DR: WHO simplify the hepatitis elimination targets, change to absolute targets and allow countries to achieve these disease targets with their own service coverage initiatives that will have the maximum impact, to help measure progress towards true elimination and motivate other countries to follow suit.